Viscosupplementation Market Research Report by Product (Five Injection, Single Injection, and Three Injection), Source, Application, End-use, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact o



The Global Viscosupplementation Market size was estimated at USD 2,394.51 million in 2020 and expected to reach USD 2,529.64 million in 2021, and is projected to grow at a CAGR 6.00% to reach USD 3,602.76 million by 2027.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2027 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Viscosupplementation to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the market was studied across Five Injection, Single Injection, and Three Injection.

Based on Source, the market was studied across Animal and Nonanimal.

Based on Application, the market was studied across Hand Osteoarthritis, Hip Osteoarthritis, and Knee Osteoarthritis.

Based on End-use, the market was studied across Hospitals and Orthopedic Clinics/Ambulatory Surgical Centers (ASCs).

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Delaware, Georgia, Illinois, Minnesota, New Hampshire, Pennsylvania, Tennessee, Vermont, and Washington. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of

COVID-19:COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Viscosupplementation Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Viscosupplementation Market, including AbbVie Inc., Alcon Inc., Anika Therapeutics, Inc., Avanos Medical, Inc., Bausch Health Companies Inc., Bioventus LLC, Contipro A.S., F. Hoffmann-La Roche AG, Ferring B.V., Fidia Farmaceutici S.p.A., Gentex Pharma, LLC, LG Life Sciences Ltd., Lifecore Biomedical, LLC, Quimfa S.A., Regen Lab SA, Sanofi S.A., Seikagaku Corporation, Smith & Nephew PLC, Teva Pharmaceutical Industries Ltd., Viatris Inc., and Zimmer Biomet.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Viscosupplementation Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Viscosupplementation Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Viscosupplementation Market?
4. What is the competitive strategic window for opportunities in the Global Viscosupplementation Market?
5. What are the technology trends and regulatory frameworks in the Global Viscosupplementation Market?
6. What is the market share of the leading vendors in the Global Viscosupplementation Market?
7. What modes and strategic moves are considered suitable for entering the Global Viscosupplementation Market?

Please Note: PDF & Excel + Online Access - 1 Year


Companies Mentioned

AbbVie Inc.
Alcon Inc.
Anika Therapeutics, Inc.
Avanos Medical, Inc.
Bausch Health Companies Inc.
Bioventus LLC
Contipro A.S.
F. Hoffmann-La Roche AG
Ferring B.V.
Fidia Farmaceutici S.p.A.
Gentex Pharma, LLC
LG Life Sciences Ltd.
Lifecore Biomedical, LLC
Quimfa S.A.
Regen Lab SA
Sanofi S.A.
Seikagaku Corporation
Smith & Nephew PLC
Teva Pharmaceutical Industries Ltd.
Viatris Inc.
Zimmer Biomet

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing Need for Non-Surgical Treatment for Osteoarthritis
5.1.1.2. Rising Occurrence of Lifestyle-Induced Disorders with Changing Eating Habits
5.1.1.3. Surge in Geriatric Population and Obesity Globally
5.1.2. Restraints
5.1.2.1. Side Effects and High Cost of The Hyaluronic Acid-Based Treatment
5.1.3. Opportunities
5.1.3.1. Ongoing Advancements in the Development of Hyaluronic Acid-Based Therapies
5.1.3.2. Extending Role of Viscosupplementation in Patellar Chondropathy
5.1.4. Challenges
5.1.4.1. Strict Regulatory Mandates for Approval and Short Duration of Lubrication and Pain Relief
5.2. Cumulative Impact of COVID-19
6. Viscosupplementation Market, by Product
6.1. Introduction
6.2. Five Injection
6.3. Single Injection
6.4. Three Injection
7. Viscosupplementation Market, by Source
7.1. Introduction
7.2. Animal
7.3. Nonanimal
8. Viscosupplementation Market, by Application
8.1. Introduction
8.2. Hand Osteoarthritis
8.3. Hip Osteoarthritis
8.4. Knee Osteoarthritis
9. Viscosupplementation Market, by End-use
9.1. Introduction
9.2. Hospitals
9.3. Orthopedic Clinics/Ambulatory Surgical Centers (ASCs)
10. Americas Viscosupplementation Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Viscosupplementation Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
12. Europe, Middle East & Africa Viscosupplementation Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. AbbVie Inc.
14.2. Alcon Inc.
14.3. Anika Therapeutics, Inc.
14.4. Avanos Medical, Inc.
14.5. Bausch Health Companies Inc.
14.6. Bioventus LLC
14.7. Contipro A.S.
14.8. F. Hoffmann-La Roche AG
14.9. Ferring B.V.
14.10. Fidia Farmaceutici S.p.A.
14.11. Gentex Pharma, LLC
14.12. LG Life Sciences Ltd.
14.13. Lifecore Biomedical, LLC
14.14. Quimfa S.A.
14.15. Regen Lab SA
14.16. Sanofi S.A.
14.17. Seikagaku Corporation
14.18. Smith & Nephew PLC
14.19. Teva Pharmaceutical Industries Ltd.
14.20. Viatris Inc.
14.21. Zimmer Biomet
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings